ArticleCardio-oncology (London, England)2024

Use of EMPAgliflozin in the prevention of CARDiotoxicity: the EMPACARD - PILOT trial.

Andrés J Daniele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.